Blanpain, Lou T. http://orcid.org/0000-0002-6022-9654
Cole, Eric R.
Chen, Emily
Park, James K.
Walelign, Michael Y.
Gross, Robert E.
Cabaniss, Brian T.
Willie, Jon T. http://orcid.org/0000-0001-9565-4338
Singer, Annabelle C. http://orcid.org/0000-0001-6003-0488
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01 NS109226, RF1 NS109226, U01NS113198)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
David and Lucile Packard Foundation (NA)
the McCamish Foundation, and the Lane Family
United States Department of Defense | Defense Advanced Research Projects Agency (DARPA-BAA-14-08)
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (T32EB025816, P41 EB018783)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01 MH120194)
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering
Emory Neuromodulation Technology Innovation Center (ENTICe) and a McCamish Parkinson’s Disease Innovation Program Blue Sky Grant
Article History
Received: 25 July 2023
Accepted: 26 March 2024
First Online: 11 April 2024
Competing interests
: A.C.S. owns shares of and serves on the Scientific Advisory Board of Cognito Therapeutics. A.C.S. is an inventor on allowed U.S. Patent Application No. 16/979,226. Her conflicts are managed by Georgia Tech. The remaining authors declare no competing interests.